Search
for

    Sort by

    Research 151–180 of 876

    1. Patient preferences in the treatment of alopecia areata: A review of the literature JAAD reviews. · 2024 · 1 citations
    2. Is There a Role for Radiofrequency Devices in Hair? Skin Appendage Disorders · 2023 · 1 citations
    3. Clinical characteristics, subtype classification, and prognostic factors of ophiasis: A retrospective study of 150 patients with therapeutic implications Journal of the American Academy of Dermatology · 2026
    4. Chitosan Nanoparticles for Topical Drug Delivery in Chemotherapy-Induced Alopecia: A Comparative Study of Five Repurposed Pharmacological Agents Pharmaceuticals · 2025
    5. Resolution of advanced conjunctival squamous cell carcinoma with cemiplimab immunotherapy, IFNα-2b, and retinoic acid treatment over 2 years of follow-up Canadian Journal of Ophthalmology · 2024
    6. Bachmann–Bupp syndrome and treatment 2023
    7. Bimatoprost versus clobetasol propionate in scalp alopecia areata: A prospective non-randomized open-label clinical trial Indian Dermatology Online Journal · 2023
    8. Bimatoprost Topical Journal of the Dermatology Nurses' Association · 2017
    9. Combined microneedling with topical vitamin D3 or bimatoprost versus microneedling alone in the treatment of alopecia areata: A comparative randomized trial Journal of Cosmetic Dermatology · 2023
    10. Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment Journal of dermatology · 2023
    11. Using qualitative methods to establish the clinically meaningful threshold for treatment success in alopecia areata Quality of Life Research · 2022 · 7 citations
    12. Managing androgenic alopecia with individualised homeopathic medicine and biochemic remedies- An evidence based single case report International Journal of Homoeopathic Sciences · 2026
    13. Male androgenetic alopecia (Part II) The Journal of Men's Health & Gender · 2005 · 9 citations
    14. Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial American Journal of Clinical Dermatology · 2024 · 4 citations
    15. Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies American Journal of Clinical Dermatology · 2026
    16. How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach Dermatology and Therapy · 2026
    17. Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study Journal of the European Academy of Dermatology and Venereology · 2021 · 7 citations
    18. Kukui nut oil (Aleurites moluccanus seed oil) promotes hair growth by activating the Nrf2/ARE-AKR1C family-PGF2α signaling axis Scientific Reports · 2026
    19. Case Report: Secondary syphilitic alopecia following non-penetrative sexual contact: a case of initial misdiagnosis Frontiers in Medicine · 2026
    20. Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies International Journal of Drug Delivery Technology · 2026
    21. Focal Asymptomatic Hair Loss in an Adolescent: A Case Report Journal of pediatrics & neonatology · 2019
    22. The biodisposition and hypertrichotic effects of bimatoprost in mouse skin Experimental dermatology · 2013 · 6 citations
    23. Efficacy of bimatoprost in treating chemotherapy-induced milphosis: A comprehensive review of randomized controlled trials JAAD reviews. · 2025
    24. Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata Drug Design Development and Therapy · 2022 · 49 citations
    25. Management of comorbid Crohn's disease and alopecia universalis with upadacitinib and oral minoxidil. PubMed · 2025
    26. Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study Dermatology and therapy · 2023
    27. Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1) Journal of the American Academy of Dermatology · 2024 · 63 citations
    28. Successful Treatment of Pediatric Alopecia Areata of the Scalp Using Topical Bimatoprost Pediatric Dermatology · 2016 · 14 citations
    29. Permanent chemotherapy-induced alopecia after hematopoietic stem cell transplantation treated with low-dose oral minoxidil JAAD case reports · 2022 · 4 citations
    30. Efficacy and Safety of Oral Betamethasone Mini-Pulses in Moderate to Severe Alopecia Areata Cureus · 2025